Several novel series of C75 derivatives were synthesized and evaluated for their FAS inhibitory activities. The results showed compound 4-methylene-2-octyl-5-oxo-tetrahydro-thiophene-3-carboxylic acid (1c) had more effective FAS inhibitory (IC(50) was 2.56 mu M and T.I. was 9.26) and potent anti-tumor activities on HL60 and Hela cells in vitro (IC(50) were 5.38 mu M and 46.10 mu M, respectively). (C) 2009 Elsevier Ltd. All rights reserved.Biochemistry & Molecular BiologyChemistry, MedicinalChemistry, OrganicSCI(E)0ARTICLE51898-19041
Inhibition of FASN has emerged as a promising therapeutic target in cancer, and numerous inhibitors ...
a-Methylenelactones have received much attention due to the biological activity exhibited by natural...
International audienceAn Asinex Gold Platinium chemical library subset of 12055 compounds was screen...
Fatty acid synthase (FASN) is a lipogenic enzyme that is highly expressed in different human cancers...
<p>During oncogenesis, cancer cells go through metabolic reprogramming to maintain their high growth...
Fatty acid synthase (FASN) is the enzyme that synthesizes fatty acids de novo in human cells. Althou...
The \u3b1-methylene-\u3b3-butyrolactone skeleton is part of many natural products with remarkable bi...
C75 is a synthetic anticancer drug that inhibits fatty acid synthase (FAS) and shows a potent anorex...
ABSTRACT: Fatty acid synthase (FASN), the enzyme responsible for de novo synthesis of free fatty aci...
De novo synthesis of fatty acids is essential to maintain intensive proliferation of cancer cells. U...
Prostate and breast cancer are the number one and number two cancer sites, respectively, for male an...
Molecular targeted therapy has been developed for cancer chemoprevention and treatment. Cancer cells...
Objective Fatty acid synthase (FASN) is overexpressed in several human cancers, including oral squam...
Inhibition of de novo palmitate synthesis via fatty acid synthase (FASN) inhibition provides an unpr...
Additional contributor: Robert Fecik (faculty mentor).Prostate cancer is the number one diagnosed ca...
Inhibition of FASN has emerged as a promising therapeutic target in cancer, and numerous inhibitors ...
a-Methylenelactones have received much attention due to the biological activity exhibited by natural...
International audienceAn Asinex Gold Platinium chemical library subset of 12055 compounds was screen...
Fatty acid synthase (FASN) is a lipogenic enzyme that is highly expressed in different human cancers...
<p>During oncogenesis, cancer cells go through metabolic reprogramming to maintain their high growth...
Fatty acid synthase (FASN) is the enzyme that synthesizes fatty acids de novo in human cells. Althou...
The \u3b1-methylene-\u3b3-butyrolactone skeleton is part of many natural products with remarkable bi...
C75 is a synthetic anticancer drug that inhibits fatty acid synthase (FAS) and shows a potent anorex...
ABSTRACT: Fatty acid synthase (FASN), the enzyme responsible for de novo synthesis of free fatty aci...
De novo synthesis of fatty acids is essential to maintain intensive proliferation of cancer cells. U...
Prostate and breast cancer are the number one and number two cancer sites, respectively, for male an...
Molecular targeted therapy has been developed for cancer chemoprevention and treatment. Cancer cells...
Objective Fatty acid synthase (FASN) is overexpressed in several human cancers, including oral squam...
Inhibition of de novo palmitate synthesis via fatty acid synthase (FASN) inhibition provides an unpr...
Additional contributor: Robert Fecik (faculty mentor).Prostate cancer is the number one diagnosed ca...
Inhibition of FASN has emerged as a promising therapeutic target in cancer, and numerous inhibitors ...
a-Methylenelactones have received much attention due to the biological activity exhibited by natural...
International audienceAn Asinex Gold Platinium chemical library subset of 12055 compounds was screen...